{
    "symbol": "LUCD",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-11 21:18:07",
    "content": " We have multiple such studies, which we expect to launch in the coming weeks, including a retrospective review of Dr. Popper\u2019s NYU experienced focused on the impact of EsoGuard on medical decision making, additionally multiple prospective clinical utility studies, including a Lucid sponsored registry at existing commercial sites, a perspective Lucid sponsored clinical utility study named CLUE C-L-U-E and prospective clinical utility studies that are institutionally sponsored at Northwell Health and at St. Joseph\u2019s Health, New Jersey. Please proceed with your question. Please proceed with your question. Please proceed with your question. Please proceed with your question. Please proceed with your question."
}